書籍情報から探す
Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1
Kanae Moriya*1,2, Hisanori Shimizu*2, Satoko Handa*1, Tadanori Sasaki*2, Yasutsuna Sasaki*3, Haruo Takahashi*4, Seigo Nakamura*5, Hitoshi Yoshida*6, Yasuhisa Kato*1
*1Division of Drug Information, Dept. of Pharmacotherapeutics, Showa University School of Pharmacy, *2Dept. of Pharmacy Service, Showa University Hospital, *3Dept. of Medicine, Division of Medical Oncology, *4Dept. of Ophthalmology, *5Dept. of Surgery, Division of Breast Surgical Oncology, and *6Dept. of Medicine, Division of Gastroenterology, Showa University School of Medicine
癌と化学療法 44 (6) 501-506, 2017.
*1Division of Drug Information, Dept. of Pharmacotherapeutics, Showa University School of Pharmacy, *2Dept. of Pharmacy Service, Showa University Hospital, *3Dept. of Medicine, Division of Medical Oncology, *4Dept. of Ophthalmology, *5Dept. of Surgery, Division of Breast Surgical Oncology, and *6Dept. of Medicine, Division of Gastroenterology, Showa University School of Medicine
癌と化学療法 44 (6) 501-506, 2017.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に913円(税込) です。
同時化学療法併用陽子線治療にて5年以上Complete Responseが得られた鼠径部リンパ節転移を伴う肛門扁平上皮癌の1例